In February 2020, the FNIH Biomarkers Consortium hosted a conference to examine progress in, and establish a path forward for, incorporating remote digital monitoring into clinical evidence generation. This highly interactive, collaborative meeting crystalised and catalysed much of the recent progress we have seen in digital measurement of health. Nearly three years later, we are launching the next iteration of the meeting, to be hosted by the ETH in Zurich, Switzerland. One of the key achievements was an increased awareness of how patient centricity is critical for success in developing new digital measures.

Meeting Overview and Aims

Co-organised with the FNIH Biomarkers Consortium, the meeting is titled “Reverse Engineering of Digital Measures.” It will build on the success of the first meeting, sharing the experiences of four extended case studies and examining progress, opportunities and challenges. The interactive case studies will involve regulators, industry, patients and innovators and emphasise how patient centricity is shaping the development and validation of new evidence across settings including regulatory interactions, reimbursement and product development.

Over two full afternoons, we will explore how human-centered, holistic, evidence-based science is being put into practice and examine how this is shaping regulatory and payer interactions, patient and human engagement, product development and embedding of digital measures into decision making throughout care delivery.

Jörg Goldhahn and Steve Hoffmann

​

The meeting will be in presence, following current Swiss hygiene guidelines, with live streaming. We are really hoping as many of you as possible will be able to attend, we want to continue the robust discussion and exchange of ideas started in the first meeting.